UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer

Journal of experimental & clinical cancer research, 2019-08, Vol.38 (1), p.312-312, Article 312

2019

Link zum Volltext

Verfügbarkeit prüfen

Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling

Kidney international reports, 2021-05, Vol.6 (5), p.1379-1396

2021

Link zum Volltext

Verfügbarkeit prüfen

NSAID acyl glucuronides and enteropathy

Current drug metabolism, 2011-03, Vol.12 (3), p.245

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacologic Targeting or Genetic Deletion of Mitochondrial Cyclophilin D Protects from NSAID-Induced Small Intestinal Ulceration in Mice

Toxicological sciences, 2010-11, Vol.118 (1), p.276-285

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract 345: Novel RAS inhibitor, MCI-062, potently and selectively inhibits the growth of KRAS mutant pancreatic tumor cells by blocking GTP loading of RAS

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.345-345

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2707: A novel RAS inhibitor, MCI-062, inhibits colon tumor growth in vivo and activates antitumor immunity

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2707-2707

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2731: A novel PDE10/beta-catenin inhibitor, MCI-048, suppresses lung tumorigenesis to block metastasis

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2731-2731

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1937: Inhibition of a novel cancer target, PDE10, suppresses Wnt/β-catenin signaling and colon tumorigenesis: Benefits from combining with ornithine decarboxylase inhibitors

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1937-1937

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 478: A novel dual-acting RAS/β-catenin inhibitor activates antitumor immunity to potentiate cancer immunotherapy

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.478-478

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract A30: Novel non-COX inhibitory sulindac derivative with PDE10 inhibitory activity reduces incidence and multiplicity of colorectal adenomas in the APC+/min-FCCC mouse model

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (3_Supplement), p.A30-A30

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract B21: PDE10A overexpression in colon cancer cells and tumors relative to normal colonocytes and colon mucosa

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (3_Supplement), p.B21-B21

2017

Link zum Volltext

Verfügbarkeit prüfen

Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

Cancer prevention research (Philadelphia, Pa.), 2021-11, Vol.14 (11), p.995-1008

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3864: A novel PDE10/β-catenin pathway inhibitor, MCI-030, for the treatment of colorectal cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3864-3864

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4822: Targeting RAS and downstream signaling in high-grade serous ovarian carcinoma with novel RAS inhibitors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4822-4822

2019

Link zum Volltext

Verfügbarkeit prüfen

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling

Oncotarget, 2017-09, Vol.8 (41), p.69264-69280

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract B54: Targeting constitutively active RAS signaling in high-grade serous ovarian carcinoma (HGSOC) with ADT-006, a novel small molecule that blocks RAS-effector interactions

Clinical cancer research, 2018-01, Vol.24 (1_Supplement), p.B54-B54

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1914: A novel celecoxib derivative that lacks COX-2 inhibition but displays potent colon tumor cell growth and PDE5 inhibitory activity

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1914-1914

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5159: Characterization of a novel class of RAS inhibitory compounds with potent anti-tumor activity

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5159-5159

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4972: Novel Ras inhibitor DC070-547 potently and selectively blocks Ras-RBD binding, EGFR binding to Ras signaling complex, EGFR activation of Ras signaling, and growth of Ras-driven lung tumor cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4972-4972

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5243: Novel non-COX inhibitory sulindac derivative with β-catenin suppressing activity reduces the formation of colorectal adenomas and adenocarcinomas in the APC +/min-FCCC mouse model

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5243-5243

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1633: ADT-030, a novel dual-acting RAS and β-catenin inhibitor with robust antitumor activity

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1633-1633

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B23: DC070-547, a novel Ras inhibitor potently and selectivity inhibits colon tumor growth in vitro and in vivo

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (3_Supplement), p.B23-B23

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4372: Phosphodiesterase 10A inhibition suppresses lung tumor cell growth by activating PKG to inhibit ras and Wnt signaling

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4372-4372

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1238: A novel Ras inhibitor potently and selectively suppresses lung tumor cell growth by blocking Ras-Raf binding

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.1238-1238

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 331: Beta-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.331-331

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAmerican Journal Of Physiology-Gastrointestinal And Liver Physiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(55)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(8)
Animals
(7)
Oncology
(6)
Biochemistry & Molecular Biology
(5)
Male
(5)
Cell Line, Tumor
(4)
Mice
(4)
Pharmacology & Pharmacy
(4)
Antineoplastic Agents - Pharmacology
(3)
Apoptosis
(3)
Cell Biology
(3)
Cell Proliferation - Drug Effects
(3)
Diclofenac
(3)
Enteropathy
(3)
Beta Catenin - Metabolism
(2)
Binding Sites
(2)
Biological And Medical Sciences
(2)
Care And Treatment
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer

Glomerulopathic Light Chain-Mesangial Cell Interactions: Sortilin-Related Receptor (SORL1) and Signaling

NSAID acyl glucuronides and enteropathy

Pharmacologic Targeting or Genetic Deletion of Mitochondrial Cyclophilin D Protects from NSAID-Induced Small Intestinal Ulceration in Mice

Abstract 345: Novel RAS inhibitor, MCI-062, potently and selectively inhibits the growth of KRAS mutant pancreatic tumor cells by blocking GTP loading of RAS

Abstract 2707: A novel RAS inhibitor, MCI-062, inhibits colon tumor growth in vivo and activates antitumor immunity

Abstract 2731: A novel PDE10/beta-catenin inhibitor, MCI-048, suppresses lung tumorigenesis to block metastasis

Abstract 1937: Inhibition of a novel cancer target, PDE10, suppresses Wnt/β-catenin signaling and colon tumorigenesis: Benefits from combining with ornithine decarboxylase inhibitors

Abstract 478: A novel dual-acting RAS/β-catenin inhibitor activates antitumor immunity to potentiate cancer immunotherapy

Abstract A30: Novel non-COX inhibitory sulindac derivative with PDE10 inhibitory activity reduces incidence and multiplicity of colorectal adenomas in the APC+/min-FCCC mouse model

Abstract B21: PDE10A overexpression in colon cancer cells and tumors relative to normal colonocytes and colon mucosa

Suppression of Colon Tumorigenesis in Mutant Apc Mice by a Novel PDE10 Inhibitor that Reduces Oncogenic β-Catenin

Abstract 3864: A novel PDE10/β-catenin pathway inhibitor, MCI-030, for the treatment of colorectal cancer

Abstract 4822: Targeting RAS and downstream signaling in high-grade serous ovarian carcinoma with novel RAS inhibitors

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling

Abstract B54: Targeting constitutively active RAS signaling in high-grade serous ovarian carcinoma (HGSOC) with ADT-006, a novel small molecule that blocks RAS-effector interactions

Abstract 1914: A novel celecoxib derivative that lacks COX-2 inhibition but displays potent colon tumor cell growth and PDE5 inhibitory activity

Abstract 5159: Characterization of a novel class of RAS inhibitory compounds with potent anti-tumor activity

Abstract 4972: Novel Ras inhibitor DC070-547 potently and selectively blocks Ras-RBD binding, EGFR binding to Ras signaling complex, EGFR activation of Ras signaling, and growth of Ras-driven lung tumor cells

Abstract 5243: Novel non-COX inhibitory sulindac derivative with β-catenin suppressing activity reduces the formation of colorectal adenomas and adenocarcinomas in the APC +/min-FCCC mouse model

Abstract 1633: ADT-030, a novel dual-acting RAS and β-catenin inhibitor with robust antitumor activity

Abstract B23: DC070-547, a novel Ras inhibitor potently and selectivity inhibits colon tumor growth in vitro and in vivo

Abstract 4372: Phosphodiesterase 10A inhibition suppresses lung tumor cell growth by activating PKG to inhibit ras and Wnt signaling

Abstract 1238: A novel Ras inhibitor potently and selectively suppresses lung tumor cell growth by blocking Ras-Raf binding

Abstract 331: Beta-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG

Aktive Filter

Suchergebnisse filtern